Citace podle APA

Ghosh, D., Venkataramani, P., Nandi, S., & Bhattacharjee, S. (2019). CRISPR–Cas9 a boon or bane: The bumpy road ahead to cancer therapeutics. Cancer Cell Int.

Styl Chicago

Ghosh, Debarati, Prabhadevi Venkataramani, Saikat Nandi, a Sonali Bhattacharjee. "CRISPR–Cas9 a Boon or Bane: The Bumpy Road Ahead to Cancer Therapeutics." Cancer Cell Int 2019.

Citace podle MLA

Ghosh, Debarati, Prabhadevi Venkataramani, Saikat Nandi, a Sonali Bhattacharjee. "CRISPR–Cas9 a Boon or Bane: The Bumpy Road Ahead to Cancer Therapeutics." Cancer Cell Int 2019.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..